Scheuerman Oded, Bruckheimer Elchanan, Marcus Nufar, Hoffer Vered, Garty Ben-Zion
Department of Pediatrics B, Schneider Children's Medical Center of Israel, Petah Tiqva, Israel.
Pediatrics. 2006 Jun;117(6):e1256-8. doi: 10.1542/peds.2005-2498. Epub 2006 May 1.
Advances in interventional cardiology have enabled the treatment of severe congenital heart defects without the need for surgery. The percutaneous closure of atrial septal defects and, more recently, ventricular septal defects is considered a safe procedure with fewer complications and less morbidity compared with surgery. We report on a 2-year-old child who developed endocarditis after ventricular septal defect closure with an Amplatzer device. The patient recovered after intravenous antibiotics and anticoagulation. To the best of our knowledge, this is the first report of endocarditis associated with ventricular septal defect closure device insertion.
介入心脏病学的进展使得无需进行手术就能治疗严重的先天性心脏缺陷。与手术相比，经皮闭合房间隔缺损，以及最近的室间隔缺损，被认为是一种安全的手术，并发症更少，发病率更低。我们报告了一名2岁儿童，在使用Amplatzer装置闭合室间隔缺损后发生了心内膜炎。患者在接受静脉抗生素和抗凝治疗后康复。据我们所知，这是第一例与室间隔缺损闭合装置植入相关的心内膜炎报告。
